Topical 5-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Evaluation of stratum corneum permeability in vitro

Journal of Controlled Release

Volumn 42, Issue 3, 1996, Pages 203-208

  Bretschko, Eleonor ^a   Szeimies, Rolf Markus ^b   Landthaler, Michael ^b   Lee, Geoffrey ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

5 Aminolevulinic acid; Basal cell carcinoma; Stratum corneum

Indexed keywords

AMINOLEVULINIC ACID; EUDRAGIT; PHOTOFRIN II;

ARTICLE; BASAL CELL CARCINOMA; CONTROLLED STUDY; DRUG ABSORPTION; DRUG RELEASE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MEMBRANE PERMEABILITY; NORMAL HUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN METASTASIS; STRATUM CORNEUM;

EID: 0030561008     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(96)01338-7     Document Type: Article

References (26)

1. [1] T. Dougherty, W. Potter and K. Weißhaupt, The structure of the active component of haematoporphyrine derivate, in: D. Doiron and C. Gomer (Eds.) Porphyrine Localisation and Treatment of Tumours, Alan R. Liss, New York, 1984, pp. 301-334.
2. [2] J. Kennedy, R. Potter and D. Pross, Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experiences. Photochem. Photobiol. 56 (1990) 143-148.
3. 14C] haematoporphyrine derivate distribution in malignant and normal tissue. Cancer Res. 39 (1979) 146-151.
4. [4] A. Barel, G. Jori, P. Romadini, A. Pagnan and S. Buffanti, Role of high, low and very low density lipoproteins in the transport and tumor delivery of haematoporphyrine in vivo. Cancer Lett. 32 (1986) 145-150.
5. [5] C. Foote. Mechanisms of photooxygenation, in: D. Doiron and C. Gomer (Eds.) Porphyrin Localisation and Treatment of Tumours, Alan R. Liss. New York, 1984, pp. 360-370.
6. [6] E. Unsold and D. Jocham, Grundlagen photodynamischer Lasertherapieverfahren. Chirurgie 59 (1988) 76-80.
7. [7] C. Gomer, N. Rucker, A. Ferrario and S. Wang, Properties and applications of photodynamic therapy. Radiat. Res. 120 (1989) 1-18.
8. [8] H. Lui and R. Anderson, Photodynamic therapy in dermatology: recent developments. Dermatol. Clinics 11 (1993) 1-13.
9. [9] T. Dougherty. K. Weißhaupt and D. Boyle, Photodynamic therapy and carrier, in: S. Hellmans and S. Roseburg (Eds.) Principles and Practices of Oncology, Lippincott. Philadelphia, 1985.
10. [10] R. Pottier, Y. Chow, I. La Plante, T. Truscott, I. Kennedy and L. Beiner. Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo. Photochem. Photobiol. 44 (1986) 679-687.
11. [11] D. Divaris, I. Kennedy and R. Pottier, Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localised protoporphyrin IX fluorescence. Am. J. Pathol. 136 (1990) 891-897.
12. [12] K. Svanberg, T. Andersson, D. Killander, I. Wang, U. Stenram, S. Andersson-Engels, R. Berg. J. Johansson and S. Svanberg, Photodynamic therapy of non-melanoma malignant tumours of the skin using topical δ-amino levulinic acid sensitization and laser irradiation. Br. J. Dermatol. 130 (1994) 743-751.
13. [13] J. Kennedy and R. Pottier, Endogenous protoporphyrin IX, a clinically useful photsensitiser for photodynamic therapy. Photochem. Photobiol. 14 (1992) 275-293.
14. [14] F. Cairnduff, M. Stringer, E. Hudson, D. Ashand and S. Brown, Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer. Br. J. Cancer 69 (1994) 605-608.
15. [15] P. Green, R. Hinz, C. Cullander, G. Yamane and R. Guy, Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro. Pharm. Res. 8 (1991) 1113-1120.
16. [16] P. Raykar, M. Fung and B. Anderson, The role of protein and lipid domains in the uptake of solutes of human stratum corneum. Pharm. Res. 5 (1988) 140-150.
17. [17] A. Kligman and E. Christophers, Preparation of isolated sheets of human stratum corneum. Arch. Dermatol. 88 (1963) 63-66.
18. [18] A. Göpferich and G. Lee, Measurement of drug diffusivity in stratum corneum membranes and a polyacrylate matrix. Int. J. Pharm. 71 (1991) 245-253.
19. [19] K. Horz and J. Reichling, Ionenpaar-Chromatographie von Aminosäuren. Bioforum 5 (1992) 155-159.
20. [20] M. Heisig, R. Lickfeldt. G. Wittum, G. Mazerkovitch and G. Lee, Non steady state models for drug permeation through human stratum corneum. I: the brick-and-mortar geometry with homogeneous phases. Pharm. Res. (in press).
21. [21] J. Crank, The Mathematics of Diffusion, Oxford University Press, London, 1974, pp. 49-53.
22. [22] J. Crank, The Mathematics of Diffusion, Oxford University Press, London, 1974, pp. 10-15.
23. [23] A. Göpferich and G. Lee. Solubility of clenbuterol in films of Eudragit NE 30 D. Drug Dev. Ind. Pharm. 18 (1992) 311-319.
24. [24] R.M. Szeimies, T. Sassy and M. Landthaler, Penetration potency of topically applied δ-aminolevulinic acid for photodynamic-therapy of basal cell carcinoma. Photochem. Photobiol. 59 (1994) 73-76.
25. [25] G. Guy and J. Hadgraft, Selection of drug candidates for transdermal drug delivery, in: R. Guy and J. Hadgraft (Eds.) Transdermal Drug Delivery, Marcel Dekker, New York, 1989.
26. [26] F. Schückler and G. Lee, Measuring the uptake of Azone into excised human stratum corneum from thin polymer films. J. Pharm. Pharmacol. 45 (1993) 162-165.